{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F9dedf2b3-a5cf-4b78-a8ea-8963db8caa51","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting \u2014 With Dr Srdan Verstovsek\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/9dedf2b3-a5cf-4b78-a8ea-8963db8caa51\"></iframe>","title":"Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting \u2014 With Dr Srdan Verstovsek","description":"\n        <p>Dr Srdan Verstovsek from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses new data with myeloproliferative neoplasms presented at the 2022 ASH Annual Meeting.</p>\n\n<p>CME information and select publications <a href=\"http://www.researchtopractice.com/OncologyTodayPostASH23/MPN\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/0feac4ca-e975-4f90-96b7-cb53aa38b7ac/cover.jpg"}